Soleno Therapeutics Inc (NASDAQ:SLNO) has a beta value of -1.48 and has seen 3.5 million shares traded in the last trading session. The company, currently valued at $1.52B, closed the last trade at $45.53 per share which meant it gained $7.64 on the day or 20.16% during that session. The SLNO stock price is -18.21% off its 52-week high price of $53.82 and 93.06% above the 52-week low of $3.16. The 3-month trading volume is 309.35K shares.

Soleno Therapeutics Inc (NASDAQ:SLNO) trade information

Sporting 20.16% in the green in last session, the stock has traded in the green over the last five days, when the SLNO stock price touched $45.53 or saw a rise of 15.37%. Year-to-date, Soleno Therapeutics Inc shares have moved 13.12%, while the 5-day performance has seen it change 21.28%. Over the past 30 days, the shares of Soleno Therapeutics Inc (NASDAQ:SLNO) have changed 6.38%.

Soleno Therapeutics Inc (SLNO) estimates and forecasts

Figures show that Soleno Therapeutics Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 89.79% over the past 6 months, with this year growth rate of 47.88%, compared to 10.50% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 58.00% and 54.30% for the next quarter.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 24.34% over the past 5 years. Earnings growth for 2024 is a modest 33.76% while over the next 5 years, the company’s earnings are expected to increase by 15.00%.

SLNO Dividends

Soleno Therapeutics Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.